• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Devex Impact
    • News
    • Health systems strengthening

    Pharmaceutical leaders call for greater investment in health systems

    Aid agencies must invest more in strengthening health systems and infrastructure to avoid the catastrophic consequences of multidrug-resistant tuberculosis, U.K. parliamentarians have warned. But prevention is not only dependent on drug development, senior figures in the pharmaceutical sector have told Devex.

    By Gabriella Jóźwiak // 25 March 2015

    Aid agencies must invest more in strengthening health systems and infrastructure to avoid many millions of people losing their lives to multidrug-resistant tuberculosis by 2050, a group of U.K. members of Parliament said on World Tuberculosis Day.

    Their call to action is backed by senior figures in the pharmaceutical sector, who told Devex preventing a resurgent TB pandemic was not only dependent on drug development.

    Research published this week by the U.K. All Party Parliamentary Group on Global TB claims 75 million people could lose their lives to MDR-TB over the next 35 years and cost the global economy $16.7 trillion.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Funding
    • Worldwide
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Gabriella Jóźwiak

      Gabriella Jóźwiak@GabriellaJ

      Gabriella Jóźwiak is an award-winning journalist based in London. Her work on issues and policies affecting children and young people in developing countries and the U.K. has been published in national newspapers and magazines. Having worked in-house for domestic and international development charities, Jóźwiak has a keen interest in organizational development, and has worked as a journalist in several countries across West Africa and South America.

    Search for articles

    Related Stories

    Global healthCould US foreign aid cuts fuel a superbug crisis?

    Could US foreign aid cuts fuel a superbug crisis?

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global HealthAt Vatican meeting, HIV advocates vow to fight past USAID setbacks

    At Vatican meeting, HIV advocates vow to fight past USAID setbacks

    Global HealthHow unregulated antibiotics are fueling drug-resistant UTIs

    How unregulated antibiotics are fueling drug-resistant UTIs

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      Closing the loop: Transforming waste into valuable resources
    • 3
      FfD4 special edition: The key takeaways from four days in Sevilla
    • 4
      The legal case threatening to upend philanthropy's DEI efforts
    • 5
      Devex Career Hub: How AI is transforming development work
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement